[Acute myeloblastic leukemia and hepatocellular carcinoma following Waldenström's macroglobulinemia]. 1990

K Yamamoto, and S Tohda, and T Miki, and T Suzuki, and K Nagata, and T Kamiyama, and O Miura, and Y Imai, and N Murakami, and A Katoh
First Department of Internal Medicine, Tokyo Medical and Dental University.

A 54-year-old man was admitted to our hospital for precise examination of pancytopenia in October 1988. He had been cut off his left femur and irradiated because of osteosarcoma in 1954. After 30 years, he was diagnosed as Waldenström's macroglobulinemia. Melphalan had been given 2 mg daily for 19 months until August 1988, when it was discontinued due to pancytopenia. Peripheral blood showed Hb 6.6 g/dl, platelet 40 x 10(3)/microliters, and WBC 2000/microliters with 33% blasts. Bone marrow showed normocellularity with 36% blasts. Although blasts were negative for peroxidase staining, surface marker analysis revealed myeloid (CD 13, CD 33) phenotypes. Chromosome analysis showed 45, XY, -7, inv (3). A CT scan of the liver showed a mass, 10 by 10 cm, compatible with hepatocellular carcinoma. He was treated with very low dose Ara-C without noticeable effect. Hepatic tumor gradually enlarged, and he died of hepatic failure. This is a rare case of quadruplicate malignancies. The chromosomal abnormality suggests that AML was secondary leukemia which might be associated with immunosuppression due to macroglobulinemia and/or melphalan therapy.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008258 Waldenstrom Macroglobulinemia A lymphoproliferative disorder characterized by pleomorphic B-LYMPHOCYTES including PLASMA CELLS, with increased levels of monoclonal serum IMMUNOGLOBULIN M. There is lymphoplasmacytic cells infiltration into bone marrow and often other tissues, also known as lymphoplasmacytic lymphoma. Clinical features include ANEMIA; HEMORRHAGES; and hyperviscosity. Lymphoma, Lymphoplasmacytoid,Macroglobulinemia,Familial Waldenstrom's Macroglobulinaemia,Lymphoma, Lymphocytic, Plasmacytoid,Primary Macroglobulinemia,Waldenstrom's Macroglobulinaemia,Waldenstrom's Macroglobulinemia,Familial Waldenstrom Macroglobulinaemia,Familial Waldenstroms Macroglobulinaemia,Lymphomas, Lymphoplasmacytoid,Lymphoplasmacytoid Lymphoma,Lymphoplasmacytoid Lymphomas,Macroglobulinaemia, Familial Waldenstrom's,Macroglobulinaemia, Waldenstrom's,Macroglobulinemia, Primary,Macroglobulinemia, Waldenstrom,Macroglobulinemia, Waldenstrom's,Waldenstrom Macroglobulinaemia,Waldenstrom's Macroglobulinaemia, Familial,Waldenstroms Macroglobulinaemia,Waldenstroms Macroglobulinemia
D008297 Male Males
D008558 Melphalan An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen. Medphalan,Merphalan,Phenylalanine Mustard,Sarcolysine,Sarkolysin,4-(Bis(2-chloroethyl)amino)phenylalanine,Alkeran,L-PAM,Mustard, Phenylalanine
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009378 Neoplasms, Multiple Primary Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites. Neoplasms, Synchronous,Neoplasms, Synchronous Multiple Primary,Multiple Primary Neoplasms,Multiple Primary Neoplasms, Synchronous,Synchronous Multiple Primary Neoplasms,Synchronous Neoplasms,Multiple Primary Neoplasm,Neoplasm, Multiple Primary,Neoplasm, Synchronous,Primary Neoplasm, Multiple,Primary Neoplasms, Multiple,Synchronous Neoplasm
D005266 Femoral Neoplasms New abnormal growth of tissue in the FEMUR. Femoral Neoplasm,Neoplasm, Femoral,Neoplasms, Femoral
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012516 Osteosarcoma A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) Sarcoma, Osteogenic,Osteogenic Sarcoma,Osteosarcoma Tumor,Osteogenic Sarcomas,Osteosarcoma Tumors,Osteosarcomas,Sarcomas, Osteogenic,Tumor, Osteosarcoma,Tumors, Osteosarcoma

Related Publications

K Yamamoto, and S Tohda, and T Miki, and T Suzuki, and K Nagata, and T Kamiyama, and O Miura, and Y Imai, and N Murakami, and A Katoh
June 1981, Haematologica,
K Yamamoto, and S Tohda, and T Miki, and T Suzuki, and K Nagata, and T Kamiyama, and O Miura, and Y Imai, and N Murakami, and A Katoh
April 1996, Sangre,
K Yamamoto, and S Tohda, and T Miki, and T Suzuki, and K Nagata, and T Kamiyama, and O Miura, and Y Imai, and N Murakami, and A Katoh
January 2000, Hepato-gastroenterology,
K Yamamoto, and S Tohda, and T Miki, and T Suzuki, and K Nagata, and T Kamiyama, and O Miura, and Y Imai, and N Murakami, and A Katoh
May 1996, Internal medicine (Tokyo, Japan),
K Yamamoto, and S Tohda, and T Miki, and T Suzuki, and K Nagata, and T Kamiyama, and O Miura, and Y Imai, and N Murakami, and A Katoh
January 1979, American journal of clinical pathology,
K Yamamoto, and S Tohda, and T Miki, and T Suzuki, and K Nagata, and T Kamiyama, and O Miura, and Y Imai, and N Murakami, and A Katoh
September 1981, Archives of internal medicine,
K Yamamoto, and S Tohda, and T Miki, and T Suzuki, and K Nagata, and T Kamiyama, and O Miura, and Y Imai, and N Murakami, and A Katoh
January 1990, Japanese journal of medicine,
K Yamamoto, and S Tohda, and T Miki, and T Suzuki, and K Nagata, and T Kamiyama, and O Miura, and Y Imai, and N Murakami, and A Katoh
July 1982, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
K Yamamoto, and S Tohda, and T Miki, and T Suzuki, and K Nagata, and T Kamiyama, and O Miura, and Y Imai, and N Murakami, and A Katoh
September 1967, Turk Tip Cemiyeti mecmuasi,
K Yamamoto, and S Tohda, and T Miki, and T Suzuki, and K Nagata, and T Kamiyama, and O Miura, and Y Imai, and N Murakami, and A Katoh
May 1977, La Nouvelle presse medicale,
Copied contents to your clipboard!